Stebbing J, Baranau YV, Baryash V, Manikhas A, et al. Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer: final results from a randomized phase III trial. Breast Cancer Res Treat 2021 Jun 20. pii: 10.1007/s10549-021-06240.
PMID: 34148205